Healthcare -
Biotechnology - NASDAQ - US
$ 0.9605
0.541 %
$ 76.9 M
Market Cap
2.54
P/E
CTMX - REVENUE
Revenue CTMX - CytomX Therapeutics, Inc.
138 M
LAST VALUE
61.17%
2 YEAR CAGR
19.16%
5 YEAR CAGR
39.14%
10 YEAR CAGR